BIOMAT Database Logo BIOMAT Database Logo

[The use of the cardioselective adrenergic beta 1-blockader cordanum in the treatment of arterial hypertension]. 1983

B Ia Zonis, and V B Brin

UI MeSH Term Description Entries
D006973 Hypertension Persistently high systemic arterial BLOOD PRESSURE. Based on multiple readings (BLOOD PRESSURE DETERMINATION), hypertension is currently defined as when SYSTOLIC PRESSURE is consistently greater than 140 mm Hg or when DIASTOLIC PRESSURE is consistently 90 mm Hg or more. Blood Pressure, High,Blood Pressures, High,High Blood Pressure,High Blood Pressures
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D009200 Myocardial Contraction Contractile activity of the MYOCARDIUM. Heart Contractility,Inotropism, Cardiac,Cardiac Inotropism,Cardiac Inotropisms,Contractilities, Heart,Contractility, Heart,Contraction, Myocardial,Contractions, Myocardial,Heart Contractilities,Inotropisms, Cardiac,Myocardial Contractions
D011412 Propanolamines AMINO ALCOHOLS containing the propanolamine (NH2CH2CHOHCH2) group and its derivatives. Aminopropanols
D004232 Diuretics Agents that promote the excretion of urine through their effects on kidney function. Diuretic,Diuretic Effect,Diuretic Effects,Effect, Diuretic,Effects, Diuretic
D004359 Drug Therapy, Combination Therapy with two or more separate preparations given for a combined effect. Combination Chemotherapy,Polychemotherapy,Chemotherapy, Combination,Combination Drug Therapy,Drug Polytherapy,Therapy, Combination Drug,Chemotherapies, Combination,Combination Chemotherapies,Combination Drug Therapies,Drug Polytherapies,Drug Therapies, Combination,Polychemotherapies,Polytherapies, Drug,Polytherapy, Drug,Therapies, Combination Drug
D006439 Hemodynamics The movement and the forces involved in the movement of the blood through the CARDIOVASCULAR SYSTEM. Hemodynamic
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000319 Adrenergic beta-Antagonists Drugs that bind to but do not activate beta-adrenergic receptors thereby blocking the actions of beta-adrenergic agonists. Adrenergic beta-antagonists are used for treatment of hypertension, cardiac arrhythmias, angina pectoris, glaucoma, migraine headaches, and anxiety. Adrenergic beta-Antagonist,Adrenergic beta-Receptor Blockader,Adrenergic beta-Receptor Blockaders,beta-Adrenergic Antagonist,beta-Adrenergic Blocker,beta-Adrenergic Blocking Agent,beta-Adrenergic Blocking Agents,beta-Adrenergic Receptor Blockader,beta-Adrenergic Receptor Blockaders,beta-Adrenoceptor Antagonist,beta-Blockers, Adrenergic,beta-Adrenergic Antagonists,beta-Adrenergic Blockers,beta-Adrenoceptor Antagonists,Adrenergic beta Antagonist,Adrenergic beta Antagonists,Adrenergic beta Receptor Blockader,Adrenergic beta Receptor Blockaders,Adrenergic beta-Blockers,Agent, beta-Adrenergic Blocking,Agents, beta-Adrenergic Blocking,Antagonist, beta-Adrenergic,Antagonist, beta-Adrenoceptor,Antagonists, beta-Adrenergic,Antagonists, beta-Adrenoceptor,Blockader, Adrenergic beta-Receptor,Blockader, beta-Adrenergic Receptor,Blockaders, Adrenergic beta-Receptor,Blockaders, beta-Adrenergic Receptor,Blocker, beta-Adrenergic,Blockers, beta-Adrenergic,Blocking Agent, beta-Adrenergic,Blocking Agents, beta-Adrenergic,Receptor Blockader, beta-Adrenergic,Receptor Blockaders, beta-Adrenergic,beta Adrenergic Antagonist,beta Adrenergic Antagonists,beta Adrenergic Blocker,beta Adrenergic Blockers,beta Adrenergic Blocking Agent,beta Adrenergic Blocking Agents,beta Adrenergic Receptor Blockader,beta Adrenergic Receptor Blockaders,beta Adrenoceptor Antagonist,beta Adrenoceptor Antagonists,beta Blockers, Adrenergic,beta-Antagonist, Adrenergic,beta-Antagonists, Adrenergic,beta-Receptor Blockader, Adrenergic,beta-Receptor Blockaders, Adrenergic
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults

Related Publications

B Ia Zonis, and V B Brin
[Treatment of hypertension with the cardioselective beta-adrenergic blockader tenormin].
January 1983, Terapevticheskii arkhiv,
B Ia Zonis, and V B Brin
[Use of the adrenergic beta receptor blockader, visken, (prindolol) in arterial hypertension].
October 1977, Kardiologiia,
B Ia Zonis, and V B Brin
[Adrenergic beta receptor blockader celiprolol in the treatment of patients with arterial hypertension].
February 1990, Klinicheskaia meditsina,
B Ia Zonis, and V B Brin
[Essential arterial hypertension. Antihypertensive effect of the beta adrenergic blockader pindolol].
January 1977, La Prensa medica mexicana,
B Ia Zonis, and V B Brin
[Use of cardioselective adrenergic beta 1 receptor blockader spesicor in patients with ischemic heart disease associated with bronchial asthma].
July 1987, Klinicheskaia meditsina,
B Ia Zonis, and V B Brin
[Test with the use of the adrenergic beta receptor blockader trasicor in the differential diagnosis of arterial hypertension].
January 1983, Sovetskaia meditsina,
B Ia Zonis, and V B Brin
[Treatment of hypertension with the alpha- and beta-adrenergic blockader trandat].
January 1983, Terapevticheskii arkhiv,
B Ia Zonis, and V B Brin
[Use of beta-blockader visken in children with primary arterial hypertension].
May 1976, Kardiologiia,
B Ia Zonis, and V B Brin
[Use of beta-adrenergic blockaders in the treatment of arterial hypertension].
March 1978, Kardiologiia,
B Ia Zonis, and V B Brin
[Own experience with labetalol - a new adrenergic alpha and beta receptor blockader - in the treatment of arterial hypertension].
August 1981, Polski tygodnik lekarski (Warsaw, Poland : 1960),
Copied contents to your clipboard!